المؤلفون: Hussein, Humaira

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, SGLT-2i, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), blood-glucose, Type 2 diabetes, thesis

الوصول الحر: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.890436Test

المصدر: Pottegård , A , Andersen , J H , Søndergaard , J , Thomsen , R W & Vilsbøll , T 2023 , ' Changes in the use of glucose-lowering drugs : A Danish nationwide study ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 4 , pp. 1002-1010 .

مصطلحات الفهرس: antidiabetics, drug utilization, glucagon-like peptide-1 receptor agonists, glucose-lowering medication, pharmacoepidemiology, sodium-glucose co-transporter-2 inhibitors, type 2 diabetes, article

URL: https://curis.ku.dk/portal/da/publications/changes-in-the-use-of-glucoselowering-drugsTest(11618378-6307-4061-a5a7-0e25d94c2c0b).html
https://doi.org/10.1111/dom.14947Test
https://curis.ku.dk/ws/files/342495143/Diabetes_Obesity_Metabolism_2022_Potteg_rd_Changes_in_the_use_of_glucose_lowering_drugs_A_Danish_nationwide_study.pdfTest

المصدر: Pottegård , A , Andersen , J H , Søndergaard , J , Thomsen , R W & Vilsbøll , T 2023 , ' Changes in the use of glucose-lowering drugs : A Danish nationwide study ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 4 , pp. 1002-1010 .

مصطلحات الفهرس: antidiabetics, drug utilization, glucagon-like peptide-1 receptor agonists, glucose-lowering medication, pharmacoepidemiology, sodium-glucose co-transporter-2 inhibitors, type 2 diabetes, article

URL: https://curis.ku.dk/portal/da/publications/changes-in-the-use-of-glucoselowering-drugsTest(11618378-6307-4061-a5a7-0e25d94c2c0b).html
https://doi.org/10.1111/dom.14947Test
https://curis.ku.dk/ws/files/342495143/Diabetes_Obesity_Metabolism_2022_Potteg_rd_Changes_in_the_use_of_glucose_lowering_drugs_A_Danish_nationwide_study.pdfTest

المصدر: Norgaard , C H , Friedrich , S , Hansen , C T , Gerds , T , Ballard , C , Moller , D V , Knudsen , L B , Kvist , K , Zinman , B , Holm , E , Torp-Pedersen , C & Morch , L S 2022 , ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ' , Alzheimers & dementia-Translational research & clinical interventions , vol. 8 , no. 1 , 12268 .

مصطلحات الفهرس: dementia, glucagon-like peptide-1 receptor agonists, randomized controlled trial, real-world evidence, type 2 diabetes, CARDIOVASCULAR OUTCOMES, MOUSE MODEL, LIRAGLUTIDE, SEMAGLUTIDE, article

URL: https://curis.ku.dk/portal/da/publications/treatment-with-glucagonlike-peptide1Test-receptor-agonists-and-incidence-of-dementia(44edaa37-999a-43d7-b050-5ed18cda3601).html
https://doi.org/10.1002/trc2.12268Test
https://curis.ku.dk/ws/files/333611486/Fulltext.pdfTest

المصدر: Shaman , A M , Bain , S C , Bakris , G L , Buse , J B , Idorn , T , Mahaffey , K W , Mann , J F E , Nauck , M A , Rasmussen , S , Rossing , P , Wolthers , B , Zinman , B & Perkovic , V 2022 , ' Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes : Pooled Analysis of SUSTAIN 6 and LEADER ' , Circulation , vol. 145 , no. 8 , pp. 575-585 .

مصطلحات الفهرس: albuminuria, chronic kidney disease, eGFR, glucagon-like peptide-1 receptor agonists, liraglutide, semaglutide, type 2 diabetes, article

URL: https://curis.ku.dk/portal/da/publications/effect-of-the-glucagonlike-peptide1Test-receptor-agonists-semaglutide-and-liraglutide-on-kidney-outcomes-in-patients-with-type-2-diabetes(88f43fa8-0ef9-4f95-adc6-66e566061ed3).html
https://doi.org/10.1161/CIRCULATIONAHA.121.055459Test
https://curis.ku.dk/ws/files/314157464/effe.pdfTest

المصدر: Norgaard , C H , Friedrich , S , Hansen , C T , Gerds , T , Ballard , C , Moller , D V , Knudsen , L B , Kvist , K , Zinman , B , Holm , E , Torp-Pedersen , C & Morch , L S 2022 , ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ' , Alzheimers & dementia-Translational research & clinical interventions , vol. 8 , no. 1 , 12268 .

مصطلحات الفهرس: dementia, glucagon-like peptide-1 receptor agonists, randomized controlled trial, real-world evidence, type 2 diabetes, CARDIOVASCULAR OUTCOMES, MOUSE MODEL, LIRAGLUTIDE, SEMAGLUTIDE, article

URL: https://curis.ku.dk/portal/da/publications/treatment-with-glucagonlike-peptide1Test-receptor-agonists-and-incidence-of-dementia(44edaa37-999a-43d7-b050-5ed18cda3601).html
https://doi.org/10.1002/trc2.12268Test
https://curis.ku.dk/ws/files/333611486/Fulltext.pdfTest

المصدر: Shaman , A M , Bain , S C , Bakris , G L , Buse , J B , Idorn , T , Mahaffey , K W , Mann , J F E , Nauck , M A , Rasmussen , S , Rossing , P , Wolthers , B , Zinman , B & Perkovic , V 2022 , ' Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes : Pooled Analysis of SUSTAIN 6 and LEADER ' , Circulation , vol. 145 , no. 8 , pp. 575-585 .

مصطلحات الفهرس: albuminuria, chronic kidney disease, eGFR, glucagon-like peptide-1 receptor agonists, liraglutide, semaglutide, type 2 diabetes, article

URL: https://curis.ku.dk/portal/da/publications/effect-of-the-glucagonlike-peptide1Test-receptor-agonists-semaglutide-and-liraglutide-on-kidney-outcomes-in-patients-with-type-2-diabetes(88f43fa8-0ef9-4f95-adc6-66e566061ed3).html
https://doi.org/10.1161/CIRCULATIONAHA.121.055459Test
https://curis.ku.dk/ws/files/314157464/effe.pdfTest

المؤلفون: Vekić, Jelena

المصدر: International Journal of Molecular Sciences

مصطلحات الفهرس: Oxidative stress, Inflammation, Hyperglycemia, Glucagon-like peptide-1 receptor agonists, Insulin resistance, Small dense LDL, article

URL: http://farfar.pharmacy.bg.ac.rs/bitstream/id/9280/Diabetes_and_Colorectal_pub_2021.pdfTest
info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS

مصطلحات الفهرس: Insulin Degludec/Liraglutide, Glucagon-like peptide-1 receptor agonists, Dual Action of Liraglutide and insulin degludec, Type 2 diabetes mellitus, Xultophy, Journal Article, VoR

URL: http://repo.lib.tokushima-u.ac.jp/115624Test
http://repo.lib.tokushima-u.ac.jp/files/public/11/115624/20210202105305615862/gsljnm_2_1_104.pdfTest

عناروين إضافية: Роль кишечной микробиоты в регуляции инкретиновых эффектов
The role of the gut microbiota in the regulation of incretin effects

المصدر: Clinical Endocrinology and Endocrine Surgery; № 1 (2020); 64-71; Clinical Endocrinology and Endocrine Surgery. Клиническая эндокринология и эндокринная хирургия; Clinical Endocrinology and Endocrine Surgery. Клінічна ендокринологія та ендокринна хірургія; 2519-2582; 1818-1384

مصطلحات الفهرس: мікробіота кишечнику, цукровий діабет 2-го типу, агоністи рецепторів глюкагоноподібного пептиду-1, 616.379-008.64:615.252.349:616-008.9.379:616-056.52, микробиота кишечника, сахарный диабет 2-го типа, агонисты рецепторов глюкагоноподобного пептида-1, intestinal microbiota, type 2 diabetes mellitus, glucagon-like peptide-1 receptor agonists, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: http://jcees.endocenter.kiev.ua/article/view/199619Test
http://jcees.endocenter.kiev.ua/article/view/199619/199818Test
http://jcees.endocenter.kiev.ua/article/view/199619/199818Test